March 28th 2025
Here are highlights from this week in Psychiatric Times, including positive clinical trial news for an ADHD treatment and an exclusive interview on the joint statement defending psychotropic medication safety.
Addressing the Cognition Crisis in Our COVID-19 World
The world is facing a cognition crisis. Here’s how to face it with measurement-based cognitive care.
Read More
Early Warnings: Neuropsychiatric Manifestations of Huntington Disease
Neuropsychiatric manifestations of Huntington disease can present decades before the motor symptoms become apparent, making the role of the psychiatrist all the more important.
Read More
Smart Growth: the Case for Measuring Brain Capital
Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?
Read More
A Recipe for Homemade Obesity: The Association Between Depression, Obesity, and Cognitive Deficits
December 31st 2020Evidence suggests that physical activity aids in alleviating mild to moderate symptoms of depression in patients and may promote clinically significant antidepressant effects.
Read More
Anti-NMDA Receptor Encephalitis With Visual Hallucinations and Cognitive Impairment
September 15th 2020In comparison to the classic presentation of schizophrenia, ANMDARE features a later age of onset, female predominance, visual hallucinations, relative lack of cognitive disorganization, and a lack of an extended prodromal period.
Read More
Medically and Psychiatrically Complicated Patients
May 26th 2017Helping patients who have significant medical illness as well as mental illness is a challenge, especially when the diagnosis is unclear. Hospital psychiatrists play a critical role in the management of these behaviorally compromised patients.
Read More